Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus

Diseases of the Esophagus

Volumn 27, Issue 7, 2014, Pages 678-684

  Gkika, E ^a   Gauler, T ^a   Eberhardt, W ^a   Stahl, M ^b   Stuschke, M ^a   Pottgen C ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b KLINIKEN ESSEN MITTE   (Germany)

Author keywords

Cervical; Chemoradiation; Esophageal cancer; Long term survival

Indexed keywords

CISPLATIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; IRIDIUM 192; ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVOR; CERVICAL ESOPHAGEAL CANCER; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DISTANT METASTASIS; DYSPHAGIA; ENDOSCOPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS CARCINOMA; ESOPHAGUS DILATATION; ESOPHAGUS FISTULA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; GASTROSTOMY; HUMAN; INDUCTION CHEMOTHERAPY; LEUKOPENIA; LONG TERM CARE; LONG TERM SURVIVAL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RECURRENT LARYNGEAL NERVE PALSY; RETROSPECTIVE STUDY; SECOND CANCER; SURVIVAL RATE; THROMBOCYTOPENIA; TRACHEOTOMY; ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; LONGITUDINAL STUDY; MIDDLE AGED; NECK; PATHOLOGY; PROCEDURES; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; ETOPOSIDE; FEMALE; FLUOROURACIL; HUMANS; INDUCTION CHEMOTHERAPY; LEUCOVORIN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NECK; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84906936873     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/dote.12146     Document Type: Article

References (38)

1. Ajani J A, Barthel J S, Bekaii-Saab T etal. NCCN Esophageal Cancer Panel. Esophageal cancer. J Natl Compr Canc Netw 2008; 6: 818-849.
2. Goodner J T. Treatment and survival in cancer of the cervical esophagus. Am J Surg 1969; 118: 673-675.
3. Lee D J, Harris A, Gillette A etal. Carcinoma of the cervical esophagus: diagnosis, management, and results. South Med J 1984; 77: 1365-1367.
4. Mendenhall W M, Sombeck M D, Parsons J T etal. Management of cervical esophageal carcinoma. Semin Radiat Oncol 1994; 4: 179-191.
5. Burmeister B H, Dickie G, Smithers B M etal. Thirty-four patients with carcinoma of the cervical esophagus treated with chemoradiation therapy. Arch Otolaryngol Head Neck Surg 2000; 126: 205-208.
6. Huang S H, Lockwood G, Brierley J etal. Effect of concurrent high-dose cisplatin chemotherapy and conformal radiotherapy on cervical esophageal cancer survival. Int J Radiat Oncol Biol Phys 2008; 71: 735-740.
7. Uno T, Isobe K, Kawakami H etal. Concurrent chemoradiation for patients with squamous cell carcinoma of the cervical esophagus. Dis Esophagus 2007; 20: 12-18.
8. Yamada K, Murakami M, Okamoto Y etal. Treatment results of radiotherapy for carcinoma of the cervical esophagus. Acta Oncol 2006; 45: 1120-1125.
9. Stuschke M, Stahl M, Wilke H etal. Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the cervical oesophagus. Oncology 1999; 57: 99-105.
10. Daiko H, Hayashi R, Saikawa M etal. Surgical management of carcinoma of the cervical esophagus. J Surg Oncol 2007; 96: 166-172.
11. Hirano S, Nagahara K, Moritani S etal. Upper mediastinal node dissection for hypopharyngeal and cervical esophagus carcinomas. Ann Otol Rhinol Laryngol 2007; 116: 290-296.
12. Marmuse J P, Koka V N, Guedon C etal. Surgical treatment of carcinoma of the proximal esophagus. Am J Surg 1995; 169: 386-390.
13. Ott K, Lordick F, Molls M etal. Limited resection and free jejunal graft interposition for squamous cell carcinoma of the cervical oesophagus. Br J Surg 2009; 96: 258-266.
14. Peracchia A, Bonavina L, Botturi M etal. Current status of surgery for carcinoma of the hypopharynx and cervical esophagus. Dis Esophagus 2001; 14: 95-97.
15. Shirakawa Y, Naomoto Y, Noma K etal. Free jejunal graft for hypopharyngeal and esophageal reconstruction. Langenbecks Arch Surg 2004; 389: 387-390.
16. Triboulet J P, Mariette C, Chevalier D etal. Surgical management of carcinoma of the hypopharynx and cervical esophagus. Arch Surg 2001; 136: 1164-1170.
17. Wang H W, Chu P Y, Kuo K T etal. A reappraisal of surgical management for squamous cell carcinoma in the pharyngoesophageal junction. J Surg Oncol 2006; 93: 468-476.
18. Kelley D J, Wolf R, Shaha A R etal. Impact of clinicopathologic parameters on patient survival in carcinoma of the cervical esophagus. Am J Surg 1995; 170: 427-431.
19. Böttger T, Bumb P, Dutkowski P etal. Carcinoma of the hypopharynx and the cervical oesophagus: a surgical challenge. Eur J Surg 1999; 165: 940-946.
20. Martins A S. Neck and mediastinal node dissection in pharyngolaryngoesophageal tumors. Head Neck 2001; 23: 772-779.
21. Miller J I, Lee R B. Free jejunal interposition of the esophagus. Semin Thorac Cardiovasc Surg 1992; 4: 286-291.
22. Welz H, Poettgen C, Abu Jawad J etal. Hyperfractionated accelerated radiotherapy versus conventional fractionation both combined with chemotherapy in patients with locally advanced head and neck carcinomas. A retrospective analysis of a monoinstitutional series. Oncology 2009; 76: 405-412.
23. Mellow M H, Pinkas H. Endoscopic laser therapy for malignancies affecting the esophagus and gastroesophageal junction. Analysis of technical and functional efficacy. Arch Intern Med 1985; 145: 1443-1446.
24. LENT SOMA tables. Radiother Oncol 1995; 35: 17-60.
25. Oken M M, Creech R H, Tormey D C etal. Toxicity and Response Criteria of Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649-655.
26. Stahl M, Stuschke M, Lehmann N etal. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005; 23: 2310-2317.
27. Stahl M, Wilke H, Fink U etal. Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial. J Clin Oncol 1996; 14: 829-837.
28. Herskovic A, Martz K, Al-Sarraf M etal. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593-1598.
29. Ho K, Fowler J, Sykes A etal. IMRT dose fractionation for head and neck cancer: variation in current approaches will make standardisation difficult. Acta Oncol 2009; 48: 431-439.
30. Ampil F L, Mills G M, Burton G V. Induction chemotherapy followed by concomitant chemoradiation for cervical esophageal cancer. Am J Gastroenterol 1999; 94: 2325-2326.
31. Tong D K, Law S, Kwong D L etal. Current management of cervical esophageal cancer. World J Surg 2011; 35: 600-607.
32. Stuschke M, Stahl M, Wilke H etal. Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the upper-thoracic and midthoracic esophagus. Am J Clin Oncol 2000; 23: 233-238.
33. Ruppert B N, Watkins J M, Shirai K etal. Cisplatin/Irinotecan versus carboplatin/paclitaxel as definitive chemoradiotherapy for locoregionally advanced esophageal cancer. Am J Clin Oncol 2010; 33: 346-352.
34. Conroy T, Yataghène Y, Etienne P L etal. Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer. Br J Cancer 2010; 103: 1349-1355.
35. Poettgen C, Stuschke M. Radiotherapy versus surgery within multimodality protocols for esophageal cancer. A meta-analysis of the randomized trials. Cancer Treat Rev 2012; 38: 599-604.
36. Fu W H, Wang L H, Zhou Z M etal. Comparison of conformal and intensity-modulated techniques for simultaneous integrated boost radiotherapy of upper esophageal carcinoma. Lung 2004; 10: 1098-1102.
37. Wang S L, Liao Z, Liu H etal. Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer. World J Gastroenterol 2006; 12: 5501-5508.
38. Welsh J, Palmer M B, Ajani J A etal. Esophageal cancer dose escalation using a simultaneous integrated boost technique. Int J Radiat Oncol Biol Phys 2012; 82: 468-474.